Role of serum response factor expression in prostate cancer biochemical recurrence.

Maria PrencipeAurelie FabreThomas Brendan MurphyEszter VargyasAmanda O'NeillAnders BjartellKristin Austlid TaskenHelene H GrytliAud SvindlandViktor BergeLars M EriWilliam GallagherR William Watson

Published in: The Prostate (2018)

SRF assessment by IHC following RP could be useful in guiding clinicians to better identify patients for appropriate follow-up and timely treatment.

Keyphrases

prostate cancer
end stage renal disease
ejection fraction
newly diagnosed
poor prognosis
prognostic factors
radical prostatectomy
replacement therapy